Neuroleptic malignant syndrome after venlafaxine

Seshagiri Rao Nimmagadda, David Hugh Ryan, Stephen Lawrence Atkin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A patient developed neuroleptic malignant syndrome after a single dose of venlafaxine with trifluoperazine treatment. A dopamine-inhibition effect induced by one dose of venlafaxine may have augmented dopamine-receptor inhibition by trifluoperazine.

Original languageEnglish
Pages (from-to)289-290
Number of pages2
JournalLancet
Volume355
Issue number9200
DOIs
Publication statusPublished - 22 Jan 2000

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Neuroleptic malignant syndrome after venlafaxine'. Together they form a unique fingerprint.

  • Cite this